Evidence map›Paper›PMID 31935292›Full record

ArticleBlood advances2020

Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor.

Steven P Grover, Clare M Schmedes, Alyson C Auriemma, Emily Butler, Molly L Parrish, Adam Miszta, Audrey C Cleuren, Mayken Visser, Stefan Heitmeier, Jens J Posma and 6 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Steven P GroverUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Clare M SchmedesUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Alyson C AuriemmaUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Emily ButlerUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Molly L ParrishUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Adam MisztaUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Audrey C CleurenLife Sciences Institute, University of Michigan, Ann Arbor, MI.
Mayken VisserBayer AG, Wuppertal, Germany.
Stefan HeitmeierBayer AG, Wuppertal, Germany.
Jens J PosmaLaboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, and.
Henri M SpronkLaboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, and.
Silvio AntoniakUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Alisa S WolbergUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
Rafal PawlinskiUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
David GailaniDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Nigel MackmanUNC Blood Research Center, Division of Hematology and Oncology, Department of Medicine, and.
University of North Carolina at Chapel Hill · USBayer (Germany) · DEMaastricht University · NLUniversity of Michigan · USVanderbilt University Medical Center · US

Funding

Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EARP, H. SHELTON · 2010 to 2020
$9.7M
Biochemistry and Pathophysiology of Factor XI and Contact ActivationR35HL140025 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 2018 to 2024
$5.5M
Fibrinogen and Factor XIII in Venous ThrombosisR01HL126974 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alisa S. Wolberg · 2016 to 2026
$4.4M
NCI NIH HHS U54 CA156733NHLBI NIH HHS R01 HL126974NHLBI NIH HHS R35 HL140025
6 · The paper itself

Abstract

The intrinsic tenase complex (FIXa-FVIIIa) of the intrinsic coagulation pathway and, to a lesser extent, thrombin-mediated activation of FXI, are necessary to amplify tissue factor (TF)-FVIIa-initiated thrombin generation. In this study, we determined the contribution of murine FIX and FXI to TF-dependent thrombin generation in vitro. We further investigated TF-dependent FIX activation in mice and the contribution of this pathway to hemostasis. Thrombin generation was decreased in FIX- but not in FXI-deficient mouse plasma. Furthermore, injection of TF increased levels of FIXa-antithrombin complexes in both wild-type and FXI-/- mice. Genetic studies were used to determine the effect of complete deficiencies of either FIX or FXI on the survival of mice expressing low levels of TF. Low-TF;FIX-/y male mice were born at the expected frequency, but none survived to wean. In contrast, low-TF;FXI-/- mice were generated at the expected frequency at wean and had a 6-month survival equivalent to that of low-TF mice. Surprisingly, a deficiency of FXI, but not FIX, exacerbated the size of blood pools in low-TF placentas and led to acute hemorrhage and death of some pregnant dams. Our data indicate that FIX, but not FXI, is essential for survival of low-TF mice after birth. This finding suggests that TF-FVIIa-mediated activation of FIX plays a critical role in murine hemostasis. In contrast, FXI deficiency, but not FIX deficiency, exacerbated blood pooling in low-TF placentas, indicating a tissue-specific requirement for FXI in the murine placenta under conditions of low TF.

Indexed as

Factor IXThromboplastinAnimalsFemaleHemostasisMaleMicePlacentaPregnancyThrombinFactor IXThrombinThromboplastin

Identifiers

PMID31935292
PMCPMC6960463
OpenAlexW2999722624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.